ArticleOncotarget2017

Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.

Rossana Maffei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.